home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

AJ Vaccines

SHARESHARESHARE
AJ Vaccines produces and sells vaccines from the production site in central Copenhagen. The production is taken over from SSI, and was until January 2017 owned by the Danish Government. AJ Vaccines has thus taken over a company with a very proud history of vaccine manufacturing
SHARESHARESHARE

RELATED NEWS


UK’s Cancer Research Technology (CRT) Pioneer Fund has announced an investment to develop a new class of drugs for blood cancer, which will target a protein called B-cell lymphoma 6 (BCL6).Scientists at the Institute of Cancer Research, London, will use the fund to support their design of the drugs, to treat patients with Diffuse Large BCL6, a sub-type of non-hodgkin lymphoma.CRT, the commercialisation arm of Cancer Research UK, and the European Investment Fund (EIF) launched the fund in 2012 to...
PHARMACEUTICAL-TECHNOLOGY.COM
READ MORE

UK patients with a rare form of lung cancer will be able to access Roche’s Alecensa without the need for prior chemotherapy before official approval is obtained, following its inclusion in the country’s Early Access to Medicines Scheme (EAMS). The Medicines and Healthcare products Regulatory Agency has issued a positive Scientific Opinion allowing use of the drug on the scheme for first-line treatment of adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (N...

READ MORE

The news that 48 NHS trusts have been by hit a ransomware attack is a timely reminder that the healthcare industry needs to take the crucial issue of cyber security far more seriously....

READ MORE

Allergan’s latest target for Botox Cosmetic is millennials. If there's any doubt, just look at the crowd of 20-somethings in its newly launched TV ad: Young people exaggerate their facial expressions surprised, embarrassed or laughing with no noticeable frown lines or forehead wrinkles. The ad notes: “Look like you with fewer lines.” The campaign, Allergan’s first specifically meant for millennial men and women, is a bid to modernize the brand and appeal to the up-and...

READ MORE

Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) will not be available to advanced bladder cancer patients for at least three years in much of the UK after NICE published final guidance that rejected the drug for regular NHS funding in this use. Following its usual review process, NICE concluded in final guidance that Opdivo is not cost-effective for treating local advanced unresectable or metastatic urothelial cancer, after platinum-based chemotherapy....
PHARMAPHORUM
READ MORE

Pfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of more effective influenza vaccines, joining other pharma giants in a promising mRNA-based race. Under the terms of the agreement, BioNTech received a $120m upfront payment consisting of a mix of cash, equity, and research support. Pfizer has also committed to an additional $305m in line with potential regulatory and commercial milestone payments depending on the future development achievement...

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...